HT
AGN

HAP Trading’s Allergan plc AGN Stock Holding History

HAP Trading’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-68,500
Closed -$299K – 1936
2020
Q1 		$299K Sell
68,500
-37,600
-35% -$7.08M 0.02% 447
2019
Q4 		$1.63M Buy
106,100
+27,200
+34% +$4.91M 0.09% 150
2019
Q3 		$597K Sell
78,900
-478,400
-86% -$77.9M 0.05% 284
2019
Q2 		$6.42M Buy
557,300
+343,816
+161% +$47.6M 0.49% 44
2019
Q1 		$5.29M Sell
213,484
-42,816
-17% -$6.21M 0.47% 49
2018
Q4 		$2K Sell
256,300
-63,018
-20% -$10.3M ﹤0.01% 1080
2018
Q3 		$18.4M Buy
319,318
+26,726
+9% +$4.91M 1.16% 17
2018
Q2 		$7.29M Buy
292,592
+199,768
+215% +$32.1M 0.36% 49
2018
Q1 		$3.28M Buy
+92,824
New +$15.6M 0.16% 102
2017
Q4 		– Sell
-11,000
Closed -$19K – 1231
2017
Q3 		$19K Sell
11,000
-64,500
-85% -$15M ﹤0.01% 759
2017
Q2 		$2.13M Sell
75,500
-11,400
-13% -$2.68M 0.11% 173
2017
Q1 		$2.24M Sell
86,900
-16,700
-16% -$3.89M 0.14% 128
2016
Q4 		$113K Sell
103,600
-73,800
-42% -$15.3M 0.01% 548
2016
Q3 		$182K Sell
177,400
-8,100
-4% -$1.98M 0.01% 519
2016
Q2 		$430K Buy
+185,500
New +$42.8M 0.03% 340
2016
Q1 		– Sell
-361,871
Closed -$37.4M – 1148
2015
Q4 		$37.4M Buy
361,871
+189,310
+110% +$56.4M 1.81% 7
2015
Q3 		$27.9M Buy
172,561
+100,161
+138% +$30.8M 1.45% 8
2015
Q2 		$728K Buy
+72,400
New +$21.6M 0.04% 310
2013
Q3 		– Sell
-90,000
Closed -$2.89M – 941
2013
Q2 		$2.89M Buy
+90,000
New +$10.2M 0.1% 190

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

HAP Trading's AGN Position: Q1 2017 in Review

HAP Trading sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 600,859 shares — an estimated $140M sold.

HAP Trading first reported a position in AGN in Q4 2016 and held it in 1 quarter. The position peaked at $126M in Q4 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • HAP Trading reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • HAP Trading sold 600,859 Allergan plc shares in Q1 2017, an estimated $140M.
  • HAP Trading first reported a position in Allergan plc in Q4 2016 and held it in 1 quarter.
  • HAP Trading's Allergan plc position peaked at $126M in Q4 2016.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on HAP Trading's 13F filing for Q1 2017, filed 12 May 2017.